Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | DHODH | Q02127 | 5/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9821993 | 0.82 | ALDH1A1 (0.36) | ALDH1A1KMT2ADHODH | |
| SCHEMBL9822071 | 0.81 | DHODH (0.36) | ALDH1A1KMT2ADHODH | |
| SCHEMBL9822408 | 0.78 | PDE10A (0.35) | ALDH1A1 | |
| SCHEMBL9822101 | 0.71 | PDE10A (0.36) | ALDH1A1 | |
| SCHEMBL9822254 | 0.68 | ALDH1A1 (0.40) | ALDH1A1 | |
| SCHEMBL18611249 | 0.68 | DHODH (0.50) | ALDH1A1KMT2ADHODH | |
| SCHEMBL10407651 | 0.67 | DHODH (0.52) | ALDH1A1KMT2ADHODH | |
| SCHEMBL10407780 | 0.66 | ALDH1A1 (0.41) | ALDH1A1KMT2ADHODH | |
| SCHEMBL9822247 | 0.65 | — | — | |
| SCHEMBL9822076 | 0.64 | DHODH (0.36) | ALDH1A1KMT2ADHODH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4987129-A | BACTERICIDES | SANKEI PHARMACEUTICAL CO., LTD. (JP) | 1991-01-22 | — | — | US | disclosed |
| US-4958019-A | Intermediates for synthesis of cephalosporin compounds | SANKEI PHARMACEUTICAL CO., LTD. (JP) | 1990-09-18 | — | — | US | disclosed |
| US-4956462-A | Bactericides, ANTIBIOTICS, CEPHALOSPORINS | SANKEI PHARMACEUTICAL CO., LTD. (JP) | 1990-09-11 | — | — | US | disclosed |
| EP-0302633-A2 | Beta-lactam compound, process for preparing the same, intermediate for synthesis of the same and medicinal composition for bacterially infectious disease therapy containing the same | SANKEI PHARMACEUTICAL COMPANY LIMITED (JP) | 1989-02-08 | — | — | EP | disclosed |